Ignite Creation Date:
2024-05-05 @ 11:14 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01286675
Status:
COMPLETED
Last Update Posted:
2019-03-01
First Post:
2011-01-28
Brief Title:
Effect of Eltrombopag Plus G-CSF on Human CD34 Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
10-346
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dana-Farber Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Nancy Berliner MD
Responsible Party Title:
Chief Division of Hematology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Dana-Farber Cancer Institute
Old Name:
None
Old Organization:
None